Turning neglected tropical diseases into forgotten maladies

Health Affairs

Volumn 28, Issue 6, 2009, Pages 1691-1706

  Musgrove, Philip ^a   Hotez, Peter J ^b,c  

^a Health Affairs ^*

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c SABIN VACCINE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AZITHROMYCIN; DIETHYLCARBAMAZINE; IVERMECTIN; MEBENDAZOLE; PRAZIQUANTEL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DISABILITY; DISEASE SEVERITY; DISEASE TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH ECONOMICS; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LYMPHATIC FILARIASIS; MALARIA; ONCHOCERCIASIS; PREVALENCE; SCHISTOSOMIASIS; TRACHOMA; TROPICAL DISEASE;

COMMUNICABLE DISEASE CONTROL; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; NEGLECTED DISEASES; POVERTY; PREVALENCE; PREVENTIVE HEALTH SERVICES; TROPICAL MEDICINE;

EID: 77952228869     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.6.1691     Document Type: Conference Paper

References (59)

1. EndPoverty2015. Goal 6: Combat HIV/AIDS, malaria, and other diseases [Internet]. New York (NY): United Nations; [cited 2009 Sep 15]. Available from htlp://www.urLorg/millenniumgoals/aids.shtml
2. Global Fund to Fight AIDS, Tuberculosis, and Malaria [Internet]. Geneva (Switzerland): Global Fund; c2009 [cited 2009 Sep 15]. Available from http://www.theglobalfund.org/en
3. Hotez PJ, Yamey G. The evolving scope of PLoS Neglected Tropical Diseases. PLoS Negl Trop Dis. 2009; 3(2):e379.
4. Hobbes T. Leviathan, The matter, forme, and power of a common wealth ecdesiasticall and civil, ch XIII. London: Andrew Cooke; 1651.
5. Hall A, Horton S, de Silva N. The costs and cost-effectiveness of mass treatment for intestinal nematode worm infections using different treatment thresholds. PloS Negl Trop Dis. 2O09;3(3):e402.
6. Hotez P. Neglected diseases amid wealth in the United States and Europe. Health Aff (Millwood). 2009;28(6):1720-5.
7. Medlin CA, Chowdhury M, Jamison DT, Measham AR. Improving the health of populations: lessons of experience. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans D, et al., editors. Disease control priorities in devdoping countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006. p. 165-79.
8. Levine R, What Works Working Group, with Kinder M. Millions saved proven successes in global health. Washington (DC): Center for Global Health; 2004.
9. Remme JHF, Feenstra P, Lever PR, Medid A, Morel C, Noma M, et al., Tropical diseases targeted for elimination: Chagas disease, lympahtic fUariasis, onchocercosis and leprosy. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans D, et al., editors. Disease control priorities in devdoping countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006. p. 433-49.
10. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans D, et al., editors. Disease control priorities in developing countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006.
11. Cattand P, Desjeux P, Guzman MG, Jannin J, Krooger A, Medid A, et aL Tropical diseases lacking adequate control measures: dengue, leishmaniasis, and African trypanosomiasis. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans D, et al., editors. Disease control priorities in devdoping countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006. p. 451-66.
12. Hotez PJ. Forgotten people, forgotten diseases: the neglected tropical diseases and their impact on global health and devdopment. Washington (DC): ASM Press; 2008.
13. Mahmoud A, Zerhouni E. Neglected tropical diseases: moving beyond mass drug treatment to understanding the sdence. Health Aff (Millwood). 2009;28(6):1726-33.
14. Daar AS, Whyte SR, Abdullah MS, Ching-Li H, Hoffman SL, Berger M. Thirty years on: taking stock and envisioning the future for the Special Programme for Research and Training in Tropical Diseases. Plos Negl Trop Dis. 2008;2(11):e314.
15. Monath TP. Yellow fever. In: Warren KS, Mahmoud AF, editors. Tropical and geographic medicine. 2nd ed. New York (NY): McGraw-Hill; 1990.661-74.
16. Enserink M. Some neglected diseases are more neglected than others. Sdence. 2009;323(5915):700.
17. Humphreys M. How four once common diseases were eliminated from the American South. Health Aff (Millwood). 2009;28(6):1734-44.
18. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the Global Burden of Disease framework. Plos Negl Trop Dis. 2007;1(2):e114.
19. Hotez P, Molyneux DH. Tropical anemia: one of Africa's greatest killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goaL PloS Negl Trop Dis. 2008;2(7):e270.
20. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. Washington (DC): World Bank and Oxford University Press; 2006. Table 5.6.
21. King CH, Dickman K, Tisch D. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005;365(9470):1561-9.
22. Rdthinger R. Leishmaniases' burden of disease: ways forward for getting from speculation to reality. PloS Negl Trop Dis. 2008;2(10):e285.
23. Hotez PJ, Bundy DAP, Beegle K, Brooker S, Drake L, de Silva N et aL Helminth infections: soil-transmitted helminth infections and schistosomiasis. In: Jamison DT, BremanJG, Measham AR, Alleyne G, Claeson M, Evans D, et aL, editors. Disease control priorities in devdoping countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006. p. 467-82.
24. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PloS Negl Trop Dis. 2006;3(5):e102.
25. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009;373(9674):1570-5.
26. King CH, Bertino AM. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PloS Negl Trop Dis. 2008;2(3):e209.
27. Hotez PJ, Fenwick A, Kjetland EF. Africa's thirty-two cents solution for HIV/AIDS. PloS Negl Trop Dis. 2009;3(5):e430.
28. Brooker S, Akhwale W, Pullan R, Estambale B, Clarke SE, Snow RW, et al. Epidemiology of plasmodium-hdminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining controL Am J Trop Med Hyg. 2007;77(6 Supp):88-98.
29. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PloS Negl Trop Dis. 2005;2(11):e336.
30. Druilhe P, Tall A, Sokhna C. Worms can worsen malaria: towards a new means to roll back malaria? Trends ParasitoL 2005;21(8):359-62.
31. Labeaud AD, Malhotra I, King MJ, King CL, King CH. Do antenatal parasite infections devalue childhood vaccination? PloS Negl Trop Dis. 2009;3(5):e442.
32. Barrett S. Polio eradication: strengthening the weakest links. Health Aff (Millwood). 2009;28(4):1079-90.
33. Bundy DA, Kremer M, Bleakley H, Jukes MC, Migud E. Deworming and devdopment: asking the right questions, asking the questions right. PloS Negl Trop Dis. 2009;3(1):e362.
34. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et aL Control of neglected tropical diseases. N Engl J Med. 2007;357(10):1018-27.
35. Emerson PM, Ngondi J. Mass antibiotic treatment alone does not eliminate ocular chlamydial infectioa PloS Negl Trop Dis. 2009;3(3):e394.
36. Cairncross S, Valdmanis V. Water supply, sanitation, and hygiene promotion. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans D, et al., editors. Disease control priorities in devdoping countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006. p. 771-92.
37. Clements AC, Bosqué-Oliva E, Sacko M, Landouré A, Dembdé R, Trapré M, et al. A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006. PLoS Negl Trop Dis. 2009;3(5):e431.
38. Cook J, Frick KD, Baltussen R, Resnikoff S, Smith A, Mecaskey J, et aL Loss of vision and hearing. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans D, et al., editors. Disease control priorities in devdoping countries. 2nd ed. New York (NY): Oxford University Press for the World Bank; 2006. p. 953-62.
39. Benderley BL The end of blinding trachoma among the world's poor is in sight [Internet]. Washington (DC): Disease Control Priorities Project; [cited 2009 Sep 15]. Available from http://dcp2.org/features/75
40. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med ParasitoL 2008;102 Suppl 1:25-9.
41. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Claeson M, et aL Advancement of global health: key messages from the Disease Control Priorities Project. Lancet. 2009;367(9517):1193-208.
42. Hotez PJ. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther. 2009;85(6):659-64.
43. Gustavsen K, Hanson C. Progress in public-private partnerships to fight neglected diseases. Health Aff (Millwood). 2009;28(6):1745-9.
44. Ottesen EA, Hooper PJ, Bradley M, Biswas G. The Global Programme to Eliminate Lymphatic Filiarisis: health impact after eight years. PLoS Negl Trop Dis. 2008;2(10):e317.
45. Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends ParasitoL 2006;22(7):285-91.
46. Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis. 2008;2(9):e300.
47. Hotez PJ, Molyneux DH. Tropical anemia: one of Africa's great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goaL PLoS Negl Trop Dis. 2008;2(7):e270.
48. US. Agency for International Devdopment. Fact sheet. 2008 Mar 7 [cited 2009 Sep 23]. http://usaid.gov/press/factsheets/2008/fs080222.html
49. UK Department for International Devdopment, £50 million to wipe out deadly tropical diseases. 2008 Sep 22 [cited 2009 Sep 24]. http://www.dfid.gov. uk/Media-Room/Press-ideases/2008/50-million-to-wipe-out-deadly-tropical-diseases
50. Hotez PJ, Thompson TG. Waging peace through neglected tropical disease control a U.S. foreign policy for the bottom billion PLoS Negl Trop Dis. 2009;3(1):e346.
51. Bitran R, Martordl B, Escobar L, Munoz R, Glassman A. Controlling and eliminating neglected diseases in Latin America and the Caribbean. Health Aff (Millwood). 2009;28(6):1707-19.
52. Laxminarayan R, Gelband H. A global subsidy: key to affordable drugs for malaria? Health Aff (Millwood). 2009;28(4):949-61.
53. Frew SE, Liu VY, Singer PA. A business plan to hdp the "Global South" in its fight against neglected diseases. Health Aff (Millwood). 2009;28(6):1760-73.
54. Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, Omune B, et al. Neglected disease research and devdopment: how much are we really spending? PLoS Med 2009;6(2):e30.
55. Ridley DB, Grabowski HG, Moe JL. Developing drugs for devdoping countries. Health Aff (Millwood). 2006;25(2):313-24.
56. Berndt ER, Hurvitz JA. Vaccine advance-purchase agreements for low-income countries: practical issues. Health Aff (Millwood). 2005;24(3):653-65.
57. Witty A. Eliminating neglected diseases in poor countries: a conversation with Andrew Witty. Interview by Susan Dentzer. Health Aff (Millwood). 2009;28(2):w411-6.
58. Hecht R, Wilson P, Palriwala A. Improving health R&D financing for devdoping countries: a menu of innovative policy options. Health Aff (Millwood). 2009;28(4):974-85.
59. Anderson GF. Spurring new research for neglected diseases. Health Aff (Millwood). 2009;28(6):1750-9.